Gybenash 600 mg 30 capsules

Gibenash 600 mg, 30 capsules

Composition:

Each tablet contains:

• Palmitoylethanolamide (PEA) - 600 mg.

Pharmacological properties:

Palmitolethanolamide (PEA) is a fatty acid amide molecule produced by the body in response to inflammation and tissue damage. It acts through:
1. Antinociceptive effect
— Reduces the sensitivity of nerve endings to pain stimuli.
2. Anti-inflammatory effect
— Modulates the activity of immune cells (especially mast cells), reducing inflammation.
3. Neuroprotection
— ​​Maintains the health of neurons and glial cells, participates in the restoration of tissues of the nervous system.

Indications for use:

• Chronic neuropathic pain (eg, diabetic neuropathy, sciatica)
• Fibromyalgia
• Interstitial cystitis
• Multiple sclerosis (as part of complex therapy)
• Inflammatory and degenerative diseases of the central nervous system
• Alternative support for anxiety disorders.

Method of administration and dosage:

• Usually taken 1 tablet (600 mg) 1-2 times a day
• The tablet should be taken after meals with water
• The duration of the course depends on the indications and is determined doctor
• Well tolerated with long-term use.